MedTrace Logo

Extracellular RNA Markers of Liver Disease and Cancer

NCT02908048 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1865

Last updated 2026-05-05

No results posted yet for this study

Summary

The study will examine and evaluate the use of extracellular RNA in blood as markers for the diagnosis of liver disease or cancer, and as markers for prediction of response to treatment or recurrence of cancer after surgery

Conditions

Interventions

OTHER

Blood samples

Blood samples collected at varying intervals over a two to three year period.

Sponsors & Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Tushar Patel, MBChB · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2024-04-02
Completion
2024-04-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02908048 on ClinicalTrials.gov